Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for Verve Therapeutics, Inc. Common Stock, par value $0.001 per share (VERV).
- Disclosed ownership: 0%.
- Date of event: 30 Jun 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 0% ownership in Verve Therapeutics, Inc. Common Stock, par value $0.001 per share (VERV) on 30 Jun 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 0% | 0 | 0 | 0 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 0% | 0 | 0 | 0 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 0% | 0 | 0 | 0 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 0% | 0 | 0 | 0 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0% | 0 | 0 | 0 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0% | 0 | 0 | 0 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 0% | 0 | 0 | 0 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 0% | 0 | 0 | 0 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 0% | 0 | 0 | 0 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 0% | 0 | 0 | 0 | /s/ Mark N. Lampert | Mark N. Lampert |